The FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are still trying to break into.
Source: https://www.cnbc.com/2024/03/14/fda-app ... icals.html
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
